MEDIKIT CO.,LTD Logo

MEDIKIT CO.,LTD

Global manufacturer of vascular access devices, IV catheters, and dialysis equipment.

7749 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
文京区湯島一丁目13番2号
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medikit Co., Ltd. is a company specializing in the development, manufacturing, and sale of medical equipment. A leading global manufacturer in the field of vascular access medical devices, its product portfolio primarily consists of IV catheters and artificial dialysis equipment, including hemodialysis catheters. Founded in 1973, Medikit is noted for creating the world's first all-in-one fistula catheter for dialysis and is a key producer of fluorine resin vascular access products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-01 02:03
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-06-25 08:42
Registration Form
確認書
Japanese 8.1 KB
2025-06-25 08:41
Governance Information
内部統制報告書-第42期(2024/04/01-2025/03/31)
Japanese 23.4 KB
2025-06-25 08:40
Annual Report
有価証券報告書-第42期(2024/04/01-2025/03/31)
Japanese 935.2 KB
2025-03-05 08:07
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-02-03 08:27
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.1 KB
2025-01-07 08:07
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.2 KB
2024-12-03 08:02
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.7 KB
2024-11-12 01:15
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-12 01:14
Interim Report
半期報告書-第42期(2024/04/01-2025/03/31)
Japanese 182.3 KB
2024-07-01 02:18
Post-Annual General Meeting Information
臨時報告書
Japanese 21.8 KB
2024-06-27 03:57
Regulatory News Service
内部統制報告書-第41期(2023/04/01-2024/03/31)
Japanese 22.4 KB
2024-06-27 03:55
Regulatory News Service
確認書
Japanese 8.1 KB
2024-06-27 03:54
Annual Report
有価証券報告書-第41期(2023/04/01-2024/03/31)
Japanese 909.0 KB
2024-02-13 01:17
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all MEDIKIT CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MEDIKIT CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
T&R Biofab Co., Ltd Logo
Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.
South Korea 246710
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.